Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells.

E. Oláh, Z. Kote, Y. Natsumeda, Y. Yamaji, G. Jarai, E. Lapis, I. Financsek, G. Weber

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

There was an overexpression of the c-myc gene (11-fold) and of the c-Ha-ras gene (2-fold) in rat hepatoma 3924A cells compared to normal rat liver as measured by dot-blot analysis of total cytoplasmic RNA. The overexpression of c-myc was attributed to a 10- to 14-fold amplification and rearrangement of the c-myc sequences as determined by Southern blot analysis. The expression of the c-myc also was dependent upon the proliferative state of the hepatoma cells. Tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide; NSC 286193), an inhibitor of the activity of IMP dehydrogenase (EC 1.1.1.205), the rate-limiting enzyme of GTP biosynthesis, resulted in a rapid drop (less than 1 h) to 50% of control in the target enzyme activity in the hepatoma cells and in a subsequent marked decrease to 55% in GTP concentration. These events were followed at 12 h of tiazofurin treatment by a 3-fold reduction in the expression of the c-myc gene and a 9-fold decline in that of the c-Ha-ras gene. These results in the hepatoma cells provide evidence in support of the earlier demonstrated correlation in K562 cells between GTP concentration and expression of c-myc and c-ras genes (Olah et al., 1989). These genes might depend on GTP for their expression in hepatoma cells and they might cooperate in a signal pathway that controls cell proliferation.

Original languageEnglish
Pages (from-to)107-117
Number of pages11
JournalCancer Biochemistry Biophysics
Volume11
Issue number2
Publication statusPublished - Apr 1990

Fingerprint

tiazofurin
ras Genes
Hepatocellular Carcinoma
Guanosine Triphosphate
Down-Regulation
Gene Expression
myc Genes
IMP Dehydrogenase
K562 Cells
Enzymes
Southern Blotting
Signal Transduction
Cell Proliferation
RNA
Liver

ASJC Scopus subject areas

  • Biophysics

Cite this

Oláh, E., Kote, Z., Natsumeda, Y., Yamaji, Y., Jarai, G., Lapis, E., ... Weber, G. (1990). Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells. Cancer Biochemistry Biophysics, 11(2), 107-117.

Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells. / Oláh, E.; Kote, Z.; Natsumeda, Y.; Yamaji, Y.; Jarai, G.; Lapis, E.; Financsek, I.; Weber, G.

In: Cancer Biochemistry Biophysics, Vol. 11, No. 2, 04.1990, p. 107-117.

Research output: Contribution to journalArticle

Oláh, E, Kote, Z, Natsumeda, Y, Yamaji, Y, Jarai, G, Lapis, E, Financsek, I & Weber, G 1990, 'Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells.', Cancer Biochemistry Biophysics, vol. 11, no. 2, pp. 107-117.
Oláh, E. ; Kote, Z. ; Natsumeda, Y. ; Yamaji, Y. ; Jarai, G. ; Lapis, E. ; Financsek, I. ; Weber, G. / Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells. In: Cancer Biochemistry Biophysics. 1990 ; Vol. 11, No. 2. pp. 107-117.
@article{40dda39b3d754a45bb6c98311c44e6f1,
title = "Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells.",
abstract = "There was an overexpression of the c-myc gene (11-fold) and of the c-Ha-ras gene (2-fold) in rat hepatoma 3924A cells compared to normal rat liver as measured by dot-blot analysis of total cytoplasmic RNA. The overexpression of c-myc was attributed to a 10- to 14-fold amplification and rearrangement of the c-myc sequences as determined by Southern blot analysis. The expression of the c-myc also was dependent upon the proliferative state of the hepatoma cells. Tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide; NSC 286193), an inhibitor of the activity of IMP dehydrogenase (EC 1.1.1.205), the rate-limiting enzyme of GTP biosynthesis, resulted in a rapid drop (less than 1 h) to 50{\%} of control in the target enzyme activity in the hepatoma cells and in a subsequent marked decrease to 55{\%} in GTP concentration. These events were followed at 12 h of tiazofurin treatment by a 3-fold reduction in the expression of the c-myc gene and a 9-fold decline in that of the c-Ha-ras gene. These results in the hepatoma cells provide evidence in support of the earlier demonstrated correlation in K562 cells between GTP concentration and expression of c-myc and c-ras genes (Olah et al., 1989). These genes might depend on GTP for their expression in hepatoma cells and they might cooperate in a signal pathway that controls cell proliferation.",
author = "E. Ol{\'a}h and Z. Kote and Y. Natsumeda and Y. Yamaji and G. Jarai and E. Lapis and I. Financsek and G. Weber",
year = "1990",
month = "4",
language = "English",
volume = "11",
pages = "107--117",
journal = "Cancer Biochemistry Biophysics",
issn = "0305-7232",
publisher = "American Cancer Society, Inc.",
number = "2",

}

TY - JOUR

T1 - Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells.

AU - Oláh, E.

AU - Kote, Z.

AU - Natsumeda, Y.

AU - Yamaji, Y.

AU - Jarai, G.

AU - Lapis, E.

AU - Financsek, I.

AU - Weber, G.

PY - 1990/4

Y1 - 1990/4

N2 - There was an overexpression of the c-myc gene (11-fold) and of the c-Ha-ras gene (2-fold) in rat hepatoma 3924A cells compared to normal rat liver as measured by dot-blot analysis of total cytoplasmic RNA. The overexpression of c-myc was attributed to a 10- to 14-fold amplification and rearrangement of the c-myc sequences as determined by Southern blot analysis. The expression of the c-myc also was dependent upon the proliferative state of the hepatoma cells. Tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide; NSC 286193), an inhibitor of the activity of IMP dehydrogenase (EC 1.1.1.205), the rate-limiting enzyme of GTP biosynthesis, resulted in a rapid drop (less than 1 h) to 50% of control in the target enzyme activity in the hepatoma cells and in a subsequent marked decrease to 55% in GTP concentration. These events were followed at 12 h of tiazofurin treatment by a 3-fold reduction in the expression of the c-myc gene and a 9-fold decline in that of the c-Ha-ras gene. These results in the hepatoma cells provide evidence in support of the earlier demonstrated correlation in K562 cells between GTP concentration and expression of c-myc and c-ras genes (Olah et al., 1989). These genes might depend on GTP for their expression in hepatoma cells and they might cooperate in a signal pathway that controls cell proliferation.

AB - There was an overexpression of the c-myc gene (11-fold) and of the c-Ha-ras gene (2-fold) in rat hepatoma 3924A cells compared to normal rat liver as measured by dot-blot analysis of total cytoplasmic RNA. The overexpression of c-myc was attributed to a 10- to 14-fold amplification and rearrangement of the c-myc sequences as determined by Southern blot analysis. The expression of the c-myc also was dependent upon the proliferative state of the hepatoma cells. Tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide; NSC 286193), an inhibitor of the activity of IMP dehydrogenase (EC 1.1.1.205), the rate-limiting enzyme of GTP biosynthesis, resulted in a rapid drop (less than 1 h) to 50% of control in the target enzyme activity in the hepatoma cells and in a subsequent marked decrease to 55% in GTP concentration. These events were followed at 12 h of tiazofurin treatment by a 3-fold reduction in the expression of the c-myc gene and a 9-fold decline in that of the c-Ha-ras gene. These results in the hepatoma cells provide evidence in support of the earlier demonstrated correlation in K562 cells between GTP concentration and expression of c-myc and c-ras genes (Olah et al., 1989). These genes might depend on GTP for their expression in hepatoma cells and they might cooperate in a signal pathway that controls cell proliferation.

UR - http://www.scopus.com/inward/record.url?scp=0025409992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025409992&partnerID=8YFLogxK

M3 - Article

C2 - 1974479

AN - SCOPUS:0025409992

VL - 11

SP - 107

EP - 117

JO - Cancer Biochemistry Biophysics

JF - Cancer Biochemistry Biophysics

SN - 0305-7232

IS - 2

ER -